BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37414253)

  • 1. Predictors of pathologic fracture and local recurrence following stereotactic body radiation therapy to 505 non-spine bone metastases.
    Nguyen EK; Korol R; Ali S; Cumal A; Erler D; Louie AV; Nguyen TK; Poon I; Cheung P; Chu W; Soliman H; Vesprini D; Sahgal A; Chen H
    Radiother Oncol; 2023 Sep; 186():109792. PubMed ID: 37414253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local control and toxicity outcomes of stereotactic radiosurgery for spinal metastases of gastrointestinal origin.
    Sandhu N; Benson KRK; Kumar KA; Eyben RV; Chang DT; Gibbs IC; Hancock SL; Meola A; Chang SD; Li G; Hayden-Gephart M; Soltys SG; Pollom EL
    J Neurosurg Spine; 2020 Mar; 33(1):87-94. PubMed ID: 32114530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging-Based Outcomes for 24 Gy in 2 Daily Fractions for Patients with de Novo Spinal Metastases Treated With Spine Stereotactic Body Radiation Therapy (SBRT).
    Tseng CL; Soliman H; Myrehaug S; Lee YK; Ruschin M; Atenafu EG; Campbell M; Maralani P; Yang V; Yee A; Sahgal A
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(3):499-507. PubMed ID: 30003994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of decompression with instrumentation on local failure following spine stereotactic radiosurgery.
    Miller JA; Balagamwala EH; Berriochoa CA; Angelov L; Suh JH; Benzel EC; Mohammadi AM; Emch T; Magnelli A; Godley A; Qi P; Chao ST
    J Neurosurg Spine; 2017 Oct; 27(4):436-443. PubMed ID: 28731393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local control and fracture risk following stereotactic body radiation therapy for non-spine bone metastases.
    Erler D; Brotherston D; Sahgal A; Cheung P; Loblaw A; Chu W; Soliman H; Chung H; Kiss A; Chow E; Poon I
    Radiother Oncol; 2018 May; 127(2):304-309. PubMed ID: 29706460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic Body Radiation Therapy for Sacral Metastases: Deviation From Recommended Target Volume Delineation Increases the Risk of Local Failure.
    Moore-Palhares D; Zeng KL; Tseng CL; Chen H; Myrehaug S; Soliman H; Maralani P; Larouche J; Shakil H; Jerzak K; Ruschin M; Zhang B; Atenafu EG; Sahgal A; Detsky J
    Int J Radiat Oncol Biol Phys; 2024 Jul; 119(4):1110-1121. PubMed ID: 38395085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-Analysis of STereotactic body radiothERapy in non-spine BONE metastaseS (MASTER-BONES).
    Moraes FY; Gouveia AG; Marta GN; da Silva MF; Hamamura AC; Tsakiridis T; Yan M; Viani GA
    Int J Radiat Oncol Biol Phys; 2024 Jan; ():. PubMed ID: 38244875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic Body Radiation Therapy for Metastatic and Recurrent Solid Tumors in Children and Young Adults.
    Tinkle CL; Singh C; Lloyd S; Guo Y; Li Y; Pappo AS; DuBois SG; Lucas JT; Haas-Kogan DA; Terezakis SA; Braunstein SE; Krasin MJ
    Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1396-1405. PubMed ID: 33259934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic body radiation therapy for sarcoma pulmonary metastases.
    Lebow ES; Lobaugh SM; Zhang Z; Dickson MA; Rosenbaum E; D'Angelo SP; Nacev BA; Shepherd AF; Shaverdian N; Wolden S; Wu AJ; Gelblum DY; Simone CB; Gomez DR; Alektiar K; Tap WD; Rimner A
    Radiother Oncol; 2023 Oct; 187():109824. PubMed ID: 37532104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local control and toxicity in a large cohort of central lung tumors treated with stereotactic body radiation therapy.
    Modh A; Rimner A; Williams E; Foster A; Shah M; Shi W; Zhang Z; Gelblum DY; Rosenzweig KE; Yorke ED; Jackson A; Wu AJ
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1168-76. PubMed ID: 25303891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic Body Radiation Therapy for Nonspine Bone Metastases: International Practice Patterns to Guide Treatment Planning.
    Nguyen TK; Sahgal A; Dagan R; Eppinga W; Guckenberger M; Kim JH; Lo SS; Redmond KJ; Siva S; Stish BJ; Tseng CL
    Pract Radiat Oncol; 2020; 10(6):e452-e460. PubMed ID: 32171852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic Body Radiation Therapy for Mediastinal and Hilar Lymph Node Metastases.
    Shahi J; Poon I; Ung YC; Tsao M; Bjarnason GA; Malik NH; Zhang L; Louie AV; Cheung P
    Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):764-774. PubMed ID: 33115687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy".
    Rieber J; Streblow J; Uhlmann L; Flentje M; Duma M; Ernst I; Blanck O; Wittig A; Boda-Heggemann J; Krempien R; Lohaus F; Klass ND; Eble MJ; Imhoff D; Kahl H; Petersen C; Gerum S; Henkenberens C; Adebahr S; Hass P; Schrade E; Wendt TG; Hildebrandt G; Andratschke N; Sterzing F; Guckenberger M
    Lung Cancer; 2016 Jul; 97():51-8. PubMed ID: 27237028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetric parameters related to occurrence of distant metastases and regional nodal relapse after SBRT for early-stage non-small cell lung cancer.
    Lalonde R; Abdelhakiem M; Keller A; Huq MS
    Radiother Oncol; 2022 Apr; 169():90-95. PubMed ID: 35202740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic body radiation therapy for benign spine tumors: is dose de-escalation appropriate?
    Kalash R; Glaser SM; Flickinger JC; Burton S; Heron DE; Gerszten PC; Engh JA; Amankulor NM; Vargo JA
    J Neurosurg Spine; 2018 Aug; 29(2):220-225. PubMed ID: 29799334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mature Imaging-Based Outcomes Supporting Local Control for Complex Reirradiation Salvage Spine Stereotactic Body Radiotherapy.
    Detsky JS; Nguyen TK; Lee Y; Atenafu E; Maralani P; Husain Z; Tseng CL; Myrehaug S; Soliman H; Sahgal A
    Neurosurgery; 2020 Sep; 87(4):816-822. PubMed ID: 32374852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-Escalated 2-Fraction Spine Stereotactic Body Radiation Therapy: 28 Gy Versus 24 Gy in 2 Daily Fractions.
    Zeng KL; Abugarib A; Soliman H; Myrehaug S; Husain ZA; Detsky J; Ruschin M; Karotki A; Atenafu EG; Larouche J; Campbell M; Maralani P; Sahgal A; Tseng CL
    Int J Radiat Oncol Biol Phys; 2023 Mar; 115(3):686-695. PubMed ID: 36309076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An international pooled analysis of SBRT outcomes to oligometastatic spine and non-spine bone metastases.
    Cao Y; Chen H; Sahgal A; Erler D; Badellino S; Biswas T; Dagan R; Foote MC; Louie AV; Poon I; Ricardi U; Redmond KJ
    Radiother Oncol; 2021 Nov; 164():98-103. PubMed ID: 34454974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological vertebral fracture after stereotactic body radiation therapy for lung metastases. Case report and literature review.
    Rodríguez-Ruiz ME; San Miguel I; Gil-Bazo I; Perez-Gracia JL; Arbea L; Moreno-Jimenez M; Aristu J
    Radiat Oncol; 2012 Mar; 7():50. PubMed ID: 22455311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal tissue complication probability of vertebral compression fracture after stereotactic body radiotherapy for de novo spine metastasis.
    Chen X; Gui C; Grimm J; Huang E; Kleinberg L; Lo L; Sciubba D; Khan M; Redmond KJ
    Radiother Oncol; 2020 Sep; 150():142-149. PubMed ID: 32540335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.